The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Porcine Vaccines Market Research Report 2025
Synopsis
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Porcine Vaccines market was valued at US$ 1345 million in 2023 and is anticipated to reach US$ 2099.7 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Vaccines.
Report Scope
The Porcine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Porcine Vaccines market was valued at US$ 1345 million in 2023 and is anticipated to reach US$ 2099.7 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Vaccines.
Report Scope
The Porcine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Porcine Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Vaccines
1.2 Porcine Vaccines Segment by Type
1.2.1 Global Porcine Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Porcine Vaccines Segment by Application
1.3.1 Global Porcine Vaccines Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Vaccines Revenue 2019-2030
1.4.2 Global Porcine Vaccines Sales 2019-2030
1.4.3 Global Porcine Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Porcine Vaccines Market Competition by Manufacturers
2.1 Global Porcine Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Porcine Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Porcine Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Vaccines, Product Type & Application
2.7 Porcine Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Porcine Vaccines Global Porcine Vaccines Sales by Region: 2019-2030
3.2.1 Global Porcine Vaccines Sales by Region: 2019-2024
3.2.2 Global Porcine Vaccines Sales by Region: 2025-2030
3.3 Global Porcine Vaccines Global Porcine Vaccines Revenue by Region: 2019-2030
3.3.1 Global Porcine Vaccines Revenue by Region: 2019-2024
3.3.2 Global Porcine Vaccines Revenue by Region: 2025-2030
3.4 North America Porcine Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Porcine Vaccines Sales by Country (2019-2030)
3.4.3 North America Porcine Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Porcine Vaccines Sales by Country (2019-2030)
3.5.3 Europe Porcine Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Porcine Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Porcine Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Porcine Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Porcine Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Porcine Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Porcine Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Vaccines Sales by Type (2019-2030)
4.1.1 Global Porcine Vaccines Sales by Type (2019-2024)
4.1.2 Global Porcine Vaccines Sales by Type (2025-2030)
4.1.3 Global Porcine Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Porcine Vaccines Revenue by Type (2019-2030)
4.2.1 Global Porcine Vaccines Revenue by Type (2019-2024)
4.2.2 Global Porcine Vaccines Revenue by Type (2025-2030)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Porcine Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Porcine Vaccines Sales by Application (2019-2030)
5.1.1 Global Porcine Vaccines Sales by Application (2019-2024)
5.1.2 Global Porcine Vaccines Sales by Application (2025-2030)
5.1.3 Global Porcine Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Porcine Vaccines Revenue by Application (2019-2030)
5.2.1 Global Porcine Vaccines Revenue by Application (2019-2024)
5.2.2 Global Porcine Vaccines Revenue by Application (2025-2030)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Porcine Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Porcine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Porcine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Corporation Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jinyu Bio-Technology Porcine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Corporation Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAHIC Porcine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Corporation Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tecon Porcine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Porcine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Porcine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Corporation Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hile Bio Porcine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Corporation Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chopper Biology Porcine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Porcine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Corporation Information
6.11.2 Hipra Porcine Vaccines Description and Business Overview
6.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hipra Porcine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Porcine Vaccines Description and Business Overview
6.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Porcine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 DHN
6.13.1 DHN Corporation Information
6.13.2 DHN Porcine Vaccines Description and Business Overview
6.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 DHN Porcine Vaccines Product Portfolio
6.13.5 DHN Recent Developments/Updates
6.14 CAVAC
6.14.1 CAVAC Corporation Information
6.14.2 CAVAC Porcine Vaccines Description and Business Overview
6.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CAVAC Porcine Vaccines Product Portfolio
6.14.5 CAVAC Recent Developments/Updates
6.15 Virbac
6.15.1 Virbac Corporation Information
6.15.2 Virbac Porcine Vaccines Description and Business Overview
6.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Virbac Porcine Vaccines Product Portfolio
6.15.5 Virbac Recent Developments/Updates
6.16 HVRI
6.16.1 HVRI Corporation Information
6.16.2 HVRI Porcine Vaccines Description and Business Overview
6.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 HVRI Porcine Vaccines Product Portfolio
6.16.5 HVRI Recent Developments/Updates
6.17 Bioveta
6.17.1 Bioveta Corporation Information
6.17.2 Bioveta Porcine Vaccines Description and Business Overview
6.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Bioveta Porcine Vaccines Product Portfolio
6.17.5 Bioveta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Vaccines Industry Chain Analysis
7.2 Porcine Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Vaccines Production Mode & Process
7.4 Porcine Vaccines Sales and Marketing
7.4.1 Porcine Vaccines Sales Channels
7.4.2 Porcine Vaccines Distributors
7.5 Porcine Vaccines Customers
8 Porcine Vaccines Market Dynamics
8.1 Porcine Vaccines Industry Trends
8.2 Porcine Vaccines Market Drivers
8.3 Porcine Vaccines Market Challenges
8.4 Porcine Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
